Literature DB >> 1892842

Recombinant human fibrinogen and sulfation of the gamma' chain.

D H Farrell1, E R Mulvihill, S M Huang, D W Chung, E W Davie.   

Abstract

Human fibrinogen and the homodimeric gamma'-chain-containing variant have been expressed in BHK cells using cDNAs coding for the alpha, beta, and gamma (or gamma') chains. The fibrinogens were secreted at levels greater than 4 micrograms (mg of total cell protein)-1 day-1 and were biologically active in clotting assays. Recombinant fibrinogen containing the gamma' chain incorporated 35SO4 into its chains during biosynthesis, while no incorporation occurred in the protein containing the gamma chain. The identity of the sulfated gamma' chain was verified by its ability to form dimers during clotting. In addition, carboxypeptidase Y digestion of the recombinant fibrinogen containing the gamma' chain released 96% of the 35S label from the sulfated chain, and the radioactive material was identified as tyrosine O-sulfate. These results clarify previous findings of the sulfation of tyrosine in human fibrinogen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892842     DOI: 10.1021/bi00103a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Role of tyrosine-sulfated proteins in retinal structure and function.

Authors:  Y Kanan; M R Al-Ubaidi
Journal:  Exp Eye Res       Date:  2015-04       Impact factor: 3.467

2.  Role of electrostatic interactions in binding of thrombin to the fibrinogen γ' chain.

Authors:  Kristine S Alexander; Michael G Fried; David H Farrell
Journal:  Biochemistry       Date:  2012-04-15       Impact factor: 3.162

3.  Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6.

Authors:  Chantelle M Rein-Smith; Nathan W Anderson; David H Farrell
Journal:  Thromb Res       Date:  2012-10-01       Impact factor: 3.944

4.  A target-specific approach for the identification of tyrosine-sulfated hemostatic proteins.

Authors:  Tzu-An Liu; Shin Yasuda; Frederick E Williams; Ming-Yih Liu; Masahito Suiko; Yoichi Sakakibara; Yuh-Shyong Yang; Ming-Cheh Liu
Journal:  Anal Biochem       Date:  2009-04-05       Impact factor: 3.365

5.  Role of fibrinogen alpha and gamma chain sites in platelet aggregation.

Authors:  D H Farrell; P Thiagarajan; D W Chung; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

6.  Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors.

Authors:  Stefano Lancellotti; Sergio Rutella; Vincenzo De Filippis; Nicola Pozzi; Bianca Rocca; Raimondo De Cristofaro
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

7.  Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.

Authors:  Santiago Marfà; Gonzalo Crespo; Vedrana Reichenbach; Xavier Forns; Gregori Casals; Manuel Morales-Ruiz; Miquel Navasa; Wladimiro Jiménez
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

8.  Complement factor H, vitronectin, and opticin are tyrosine-sulfated proteins of the retinal pigment epithelium.

Authors:  Yogita Kanan; Joseph C Siefert; Michael Kinter; Muayyad R Al-Ubaidi
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

Review 9.  Fibrinogen, Fibrinogen-like 1 and Fibrinogen-like 2 Proteins, and Their Effects.

Authors:  Nurul H Sulimai; Jason Brown; David Lominadze
Journal:  Biomedicines       Date:  2022-07-15

10.  Zeolite Nanoparticles for Selective Sorption of Plasma Proteins.

Authors:  M Rahimi; E-P Ng; K Bakhtiari; M Vinciguerra; H Ali Ahmad; H Awala; S Mintova; M Daghighi; F Bakhshandeh Rostami; M de Vries; M M Motazacker; M P Peppelenbosch; M Mahmoudi; F Rezaee
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.